Eisele Jeffrey (CIK 0001827326)

Latest company ownership

APLS - Apellis Pharmaceuticals, Inc.
Role: Chief Development Officer
Shares held
55,312
Last filed at
Jan 30, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2021Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 29, 2025 Jan 30, 2025 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 50.0 -278 -0.50% ✗ $8.2K
Jan 22, 2025 Jan 23, 2025 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 46.3 -1,291 -2.27% ✗ $39.3K
Jan 13, 2025 Jan 14, 2025 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 52.5 -264 -0.46% ✗ $7.6K
Dec 23, 2024 Dec 27, 2024 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 52.5 -63 -0.11% ✗ $2.1K
Jan 29, 2024 Jan 31, 2024 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 41.3 -1,250 -2.14% ✓ $81.5K
Jan 23, 2024 Jan 24, 2024 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 22.5 -7,378 -11.21% ✓ $469.9K
Jan 22, 2024 Jan 23, 2024 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 42.5 -1,607 -2.38% ✗ $104.4K
Jan 17, 2024 Jan 18, 2024 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 30.0 -5,207 -7.17% ✓ $341.5K
Jan 16, 2024 Jan 17, 2024 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 91.3 +19,070 35.59% ✗ $29.3K
Dec 26, 2023 Dec 28, 2023 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 51.3 -303 -0.56% ✓ $18.1K
Feb 23, 2023 Feb 27, 2023 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 41.3 -1,646 -2.96% ✓ $113.2K
Feb 21, 2023 Feb 22, 2023 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 91.3 +9,061 19.50% ✗ $48.3K
Jan 30, 2023 Jan 31, 2023 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 48.8 -883 -1.86% ✓ $46.6K
Jan 27, 2023 Jan 30, 2023 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 36.3 -367 -0.77% ✗ $19.4K
Jan 23, 2023 Jan 25, 2023 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 28.8 -4,479 -8.58% ✓ $231K
Jan 20, 2023 Jan 24, 2023 Apellis Pharmaceuticals, Inc. Chief Development Officer Sell 22.5 -2,033 -3.75% ✗ $105.8K
Apr 25, 2022 Dec 23, 2022 Apellis Pharmaceuticals, Inc. Exec VP, Program Team Lead Sell 47.5 -1,339 -4.06% ✗ $4.6K
Jan 28, 2022 Feb 1, 2022 Apellis Pharmaceuticals, Inc. Exec VP, Program Team Lead Sell 46.3 -434 -1.30% ✗ $16.7K
Dec 22, 2021 Dec 23, 2021 Apellis Pharmaceuticals, Inc. Exec VP, Program Team Lead Sell 47.5 -89 -1.19% ✗ $4.3K